Thus, high levels of expression of either MYC or MYCN due to translocations hijacking next to the HAND2 super-enhancer produce neuroblastoma cells that are resistant to the effects of ATRA in inducing neuroblastoma cell differentiation. The gene discussed is MYC; the disease is neuroblastoma.